General Information of Drug (ID: DMC82XN)

Drug Name
ASN04421891 Drug Info
Synonyms ASN 04421891; ASN-04421891
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
3187704
TTD Drug ID
DMC82XN

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
LTE4 DMCPB0Q Discovery agent N.A. Investigative [3]
UDP-glucose DMLT4JA Discovery agent N.A. Investigative [4]
LTC4 DM702WR Discovery agent N.A. Investigative [4]
LTD4 DMIUZX3 Discovery agent N.A. Investigative [4]
ASN04450772 DMKR69T Discovery agent N.A. Investigative [2]
ASN06917370 DMA20JP Discovery agent N.A. Investigative [2]
ASN02563583 DMEO3Y4 Discovery agent N.A. Investigative [2]
ASN04885796 DMQ0VZ8 Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Uracil nucleotide/cysteinyl leukotriene receptor (GPR17) TTMPART GPR17_HUMAN Agonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5518).
2 In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases. J Comput Aided Mol Des. 2011 Aug;25(8):743-52.
3 The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One. 2008;3(10):e3579.
4 The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 2006 Oct 4;25(19):4615-27.